Contents
Article 10Consultation of stakeholder organisations during joint clinical assessments#
At specific steps and timeframes during the joint clinical assessment which the JCA Subgroup considers to be appropriate, it may give the opportunity to patient organisations, healthcare professional organisations or clinical and learned societies via the members of the stakeholder network established pursuant to Article 29 of Regulation (EU) 2021/2282 to provide input on any of the following matters:
(a)medical condition;
(b)therapeutic area;
(c)medical device under assessment;
(d)comparator health technologies;
(e)other areas relevant for the joint clinical assessment of the medical device.
The input referred to in the first subparagraph shall be sought, and provided, via the HTA secretariat.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.